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ABSTRACT: Two variations of the Overman rearrangement
have been developed for the highly selective synthesis of anti-
vicinal amino alcohol natural products. A MOM ether-directed
palladium(II)-catalyzed rearrangement of an allylic trichlor-
oacetimidate was used as the key step for the preparation of
the protein kinase C inhibitor D-erythro-sphinganine and the
antitumor agent (+)-spisulosine, whereas the Overman rearrangement of chiral allylic trichloroacetimidates generated by the
asymmetric reduction of an α,β-unsaturated methyl ketone allowed rapid access both to D-ribo-phytosphingosine and L-arabino-
phytosphingosine.
■ INTRODUCTION
Sphingoid-type bases that contain vicinal amino alcohols are
key structural and functional components of the plasma
membranes of nearly all eukaryotic cells. The sphingolipids
that they form play a crucial role in many physiological
processes1 and are implicated in many common human
diseases, including diabetes,2 cancer,3 and various neurological
syndromes.4 The parent sphingoid-type bases also display
potent biological activity. For example, D-erythro-sphingosine
(1) and D-erythro-sphinganine (2) both strongly inhibit protein
kinase C,5 whereas D-ribo-phytosphingosine (3) is a potential
heat-stress signal in yeast cells.6 More simple structures from
this family of natural products also display potent biological
properties. Spisulosine (4), originally isolated from the clam
Spisula polynyma, has been shown to have signiﬁcant cytotoxic
activity by the disassembly of actin stress ﬁbers.7
Because of their biological signiﬁcance and the complicated
isolation of sphingolipids from natural sources, methods for the
asymmetric synthesis of these compounds and their derivatives
have received considerable attention.8−11 A common approach
involves the preparation of the anti-vicinal amino-alcohol motif
using starting materials from the chiral pool, such as
carbohydrates and amino acids. In particular, several members
of the sphingoid family of natural products have been
synthesized by the stereoselective addition of nucleophiles to
aldehydes derived from serine.9b,d,g,10d,11d Recently, more
speciﬁc methods, including the addition of allenylzinc
complexes to chiral sulﬁnyl imines,9k an asymmetric Henry
reaction involving a chiral copper complex,11h and the
nucleophilic ring opening of chiral aziridine-derived sulfama-
tes,11g have all been used as the key step for the preparation of
the anti-vicinal amino-alcohol moiety in these natural products.
In 2005, we reported a new approach for the preparation of
anti-vicinal amino alcohols using a palladium(II)-catalyzed
ether-directed Overman rearrangement.12 Mechanistic studies
with a range of substrates showed that an ether oxygen atom
adjacent to an allylic trichloroacetimidate can direct the facial
complexation of the Pd(II)-catalyst and the subsequent
rearrangement, resulting in the preparation of allylic anti-vicinal
amino alcohols in high diastereoselectivity (Scheme 1).13 Since
then, we have shown that the products of this process can be
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Figure 1. D-erythro-Sphingosine (1), D-erythro-sphinganine (2), D-ribo-
phytosphingosine (3), and (+)-spisulosine (4).
Scheme 1. Ether-Directed Overman Rearrangement for the
Preparation of anti-Vicinal Amino Alcohols
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transformed into various natural products, including β-hydroxy-
α-amino acids,14 the alkaloids α-conhydrine15 and (+)-monan-
chorin16 as well as several members of the clavaminol family.17
In our continuing studies of how the stereogenic centers within
a molecule can inﬂuence the outcome of rearrangement
reactions, we were interested in investigating the use of
directed Overman rearrangements for the general preparation
of sphingoid-type bases. We now report the synthesis of D-
erythro-sphinganine (2) and the antitumor agent (+)-spisulo-
sine (4)7,11 using a MOM ether-directed Pd(II)-catalyzed
Overman rearrangement to create the key anti-vicinal amino-
alcohol moiety. We also describe a novel strategy for the
preparation of D-ribo-phytosphingosine (3) and L-arabino-
phytosphingosine (35) using an Overman rearrangement of a
chiral allylic trichloroacetimidate.
■ RESULTS AND DISCUSSION
Our investigation began with the preparation of a suitable
allylic-alcohol substrate for the ether-directed Overman
rearrangement that would ultimately yield both D-erythro-
sphinganine (2) and (+)-spisulosine (4). Initially, a chiral diol
was prepared by a Sharpless asymmetric dihydroxylation of 1-
heptadecene.18 As with other long-chain terminal alkenes,
dihydroxylation of 5 gave diol 6 in only modest enantiomeric
excess (86%).19 However, recrystallization from ethyl acetate
allowed isolation of 6 in >99% enantiomeric excess and in 87%
yield. The primary and secondary hydroxyl groups of 6 were
then selectively protected using TBDMS and MOM ethers,
respectively, under standard conditions, giving 7 in quantitative
yield. Removal of the TBDMS protecting group was followed
by a one-pot Swern oxidation/Horner−Wadsworth−Emmons
reaction of 8 with triethyl phosphonoacetate under Masa-
mune−Roush conditions.20 This gave exclusively E-α,β-
unsaturated ester 9. DIBAL-H reduction of 9 completed the
seven-step synthesis of allylic alcohol 10 in 68% overall yield
(Scheme 2).
Allylic alcohol 10 was transformed into corresponding allylic
trichloroacetimidate 11 using trichloroacetonitrile and DBU,
and this was treated with bis(acetonitrile)palladium(II)
chloride (10 mol %) to aﬀect the key Overman rearrangement
(Scheme 3).21 p-Benzoquinone was also added to the directed
rearrangement reaction because previous studies have shown
that this prevents the side reaction that forms the [1,3]-product
via a Pd(0)-catalyzed process.13−17 Analysis of the 1H NMR
spectrum of the crude material from this reaction showed the
presence of the erythro- and threo-allylic trichloroacetamides in
a 28:1 diastereomeric ratio, respectively. Puriﬁcation by column
chromatography allowed the isolation of major erythro-
diastereomer 12 in 78% yield from allylic alcohol 10. To
complete the synthesis of D-erythro-sphinganine (2), alkene 12
was subjected to ozonolysis followed by a reductive workup,
which gave alcohol 13 in 78% yield.22 Removal of both
protecting groups under acid-mediated conditions completed
the 11-step synthesis of D-erythro-sphinganine (2) in 41%
overall yield.
Alcohol 13 was also used as an intermediate for the synthesis
of the antitumor agent (+)-spisulosine (4) (Scheme 4).
Activation of the primary alcohol as the mesylate followed by
displacement with sodium bromide gave bromide 14 in good
yield. Cleavage of the C−Br bond by hydrogenation also
resulted in the reduction of the trichloromethyl group to give
N-acetyl derivative 15 in 68% yield. Hydrolysis of the N-acetyl
group and removal of the MOM protecting group by treatment
with 6 M hydrochloric acid gave (+)-spisulosine (4) in
quantitative yield.
Having successfully completed the synthesis of D-erythro-
sphinganine (2) and (+)-spisulosine (4) using a highly
diastereoselective MOM ether-directed Overman rearrange-
ment as the key step, a similar strategy was proposed for the
synthesis of D-ribo-phytosphingosine (3). A nine-step synthesis
was developed from D-ribose (16) to allylic alcohol 24 (a
precursor deemed suitable for a directed Overman rearrange-
ment; Scheme 5). D-Ribose (16) was converted under standard
conditions to 2,3-isopropylidine-1-methoxy-D-ribofuranoside
(17).23 Iodination of 17 then allowed Vasella fragmentation
in the presence of zinc and acetic acid to give aldehyde 19.24
Attempts at the isolation of 19 led to the formation of a mixture
of diastereomers as well as substantial decomposition. There-
Scheme 2. Synthesis of Allylic Alcohol 10
Scheme 3. Synthesis of D-erythro-Sphinganine (2)
Scheme 4. Synthesis of (+)-Spisulosine (4)
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fore, before isolation the aldehyde was reduced at 0 °C with
sodium borohydride to give alcohol 20 in 89% yield over the
two steps. Installation of the lipid side chain was then achieved
by cross metathesis of 20 with 1-tetradecene using Grubbs
second-generation catalyst (5 mol %). Hydrogenation of the
resulting alkene and puriﬁcation gave 22 in 82% yield over the
two steps. The synthesis of allylic alcohol 24 was then
completed using a one-pot Swern oxidation/Horner−Wads-
worth−Emmons reaction of alcohol 22, followed by DIBAL-H
reduction of the ester. Optimization of this nine-step route
allowed the scalable synthesis of allylic alcohol 24 in 40%
overall yield.
With allylic alcohol 24 in hand, a directed Overman
rearrangement was attempted. Initially, allylic alcohol 24 was
converted to allylic trichloroacetimidate 25 using trichloroace-
tonitrile and DBU (Scheme 6). The 1H NMR spectrum of the
crude material from this reaction conﬁrmed a complete
conversion. However, the attempted rearrangement using
various Pd(II) catalysts, including bis(acetonitrile)palladium-
(II) chloride, gave none of the desired allylic trichloroacetamide
products. Instead, substantial decomposition of the starting
material was observed resulting from the loss of the acetonide
protecting group. The steric bulk surrounding the alkene
moiety of 25 likely results in a slow rearrangement and allows
other competing pathways to come to prominence, such as the
Pd(II)-mediated hydrolysis of the acetonide group.25,26 Over-
man rearrangement of 25 was achieved under thermal
conditions. Although this process did give allylic trichloroace-
tamides 26 and 27 in 70% yield over the two steps, the reaction
took 60 h to complete and gave undesired diastereomer 26 as
the major product (26/27, 1.7:1). Scheme 6 shows the
proposed chairlike intermediates in which the side chains adopt
a conformation that minimizes allylic 1,3-strain.27 Inspection of
the intermediate leading to allylic trichloroacetamide 26 shows
that a hydrogen bond between the imidate hydrogen atom and
the adjacent acetonide oxygen may account for its preferred
formation.
Because of the problems associated with the rearrangement
of allylic trichloroacetimidate 25, an alternative approach for
the synthesis of D-ribo-phytosphingosine (3) was devised. It was
proposed that the chiral amino group could be incorporated via
an Overman rearrangement of a chiral allylic secondary alcohol.
This was prepared in a two-stage approach from previously
synthesized alcohol 22. Swern oxidation followed by a Horner−
Wadsworth−Emmons reaction with dimethyl 2-oxopropyl-
phosphonate gave E-α,β-unsaturated ketone 28 in 79% yield
(Scheme 7). Various methods were then investigated for the
stereoselective reduction of 28. The most eﬀective trans-
formation was found using the CBS oxazaborolidines.28 The
reduction of 28 using 1 equiv of (R)-CBS-Me in the presence
of borane−THF gave (2S)-allylic alcohol 29 as a single
diastereomer in 99% yield. Alternatively, the reduction of 28
under the same conditions using (S)-CBS-Me gave (2R)-allylic
alcohol 30 in 64% yield.
The stereogenic center formed by reduction of ketone 28
was then used to install the amino group required for D-ribo-
phytosphingosine (3) (Scheme 8). (2S)-Allylic alcohol 29 was
Scheme 5. Synthesis of Allylic Alcohol 24
Scheme 6. Overman Rearrangement of Allylic
Trichloroacetimidate 25
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converted to the corresponding allylic trichloroacetimidate, and
various conditions were explored for the Overman rearrange-
ment.29 It was found that standard thermal conditions (K2CO3,
p-xylene, and 140 °C) gave after 12 h allylic trichloroacetamide
31 as a single diastereomer in 71% yield over the two steps.
However, the use of microwave heating at the same
temperature allowed the preparation of 31 in similar yield
after only 15 min. The ozonolysis of 31 followed by a reductive
workup with sodium borohydride gave alcohol 32 in 73% yield.
The synthesis of D-ribo-phytosphingosine (3) was then
completed using a two-step approach involving the basic
hydrolysis of the trichloroacetamide group and acid-mediated
removal of the acetonide protecting group.30 This gave D-ribo-
phytosphingosine (3) after 13-steps in 19% overall yield. Using
(2R)-allylic alcohol 30, the formation of the allylic trichlor-
oacetimidate and Overman rearrangement using microwave
heating gave (4R)-diastereomer 33 in a similar manner
(Scheme 8). Conversion to alcohol 34 by ozonolysis was
then followed by the two-step deprotection approach, which
completed the synthesis of L-arabino-phytosphingosine (35)
after 13-steps in 12% overall yield.
■ CONCLUSIONS
New synthetic routes have been developed for the preparation
of allylic alcohols bearing chiral hydroxyl side chains, and these
have been used to study the diastereoselective outcome of the
Overman rearrangement for the selective preparation of anti-
vicinal amino alcohols. In particular, the use of a MOM ether-
directed palladium(II)-catalyzed Overman rearrangement gave
the corresponding (3S,4R)-allylic trichloroacetamide in a
diastereomeric ratio of 28:1, and this synthetic intermediate
was converted to the natural products D-erythro-sphinganine
(2) and (+)-spisulosine (4). Alternatively, the asymmetric
reduction of an α,β-unsaturated methyl ketone using the CBS
oxazaborolidines followed by Overman rearrangement of the
resulting allylic trichloroacetimidate under microwave heating
allowed rapid access to both D-ribo-phytosphingosine (3) and L-
arabino-phytosphingosine (35). This work has generated
further insight into the scope and limitations of the Overman
rearrangement of allylic trichloroacetimidates bearing stereo-
genic centers using either metal-catalyzed or thermal
conditions. Current studies are underway to investigate
additional applications of these highly selective rearrangements
for use in natural product synthesis.
■ EXPERIMENTAL SECTION
All reagents and starting materials were obtained from commercial
sources and used as received. All dry solvents were puriﬁed using a
solvent puriﬁcation system. All reactions were performed under an
atmosphere of argon unless otherwise mentioned. Brine refers to a
saturated solution of sodium chloride. Flash column chromatography
was performed using silica gel 60 (35−70 μm). Aluminum-backed
plates precoated with silica gel 60F254 were used for thin layer
chromatography and were visualized with a UV lamp or by staining
with potassium permanganate. 1H NMR spectra were recorded on a
NMR spectrometer at either 400 or 500 MHz, and data are reported as
follows: chemical shift in ppm relative to tetramethylsilane as the
internal standard, multiplicity (s = singlet, d = doublet, t = triplet, q =
quartet, m = multiplet or overlap of nonequivalent resonances,
integration). 13C NMR spectra were recorded on a NMR spectrometer
at either 101 or 126 MHz, and data are reported as follows: chemical
shift in ppm relative to tetramethylsilane or the solvent as the internal
standard (CDCl3, δ 77.0 ppm or CD3OD, δ 44.0 ppm), multiplicity
with respect to proton (deduced from DEPT experiments, C, CH,
CH2 or CH3). The infrared spectra were recorded on a FTIR
spectrometer; wavenumbers are indicated in cm−1. Mass spectra were
recorded using electron-impact, chemical-ionization, electrospray, or
Scheme 7. Synthesis and Stereoselective Reduction of α,β-
Unsaturated Ketone 28
Scheme 8. Synthesis of D-ribo-Phytosphingosine (3) and L-arabino-Phytosphingosine (35)
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fast-atom-bombardment techniques. HRMS spectra were recorded
using a dual-focusing magnetic analyzer mass spectrometer. Melting
points are uncorrected. The optical rotations were determined as
solutions irradiating with the sodium D line (λ = 589 nm) using a
polarimeter. The [α]D values are given in units of 10
−1 deg cm2 g−1.
The chiral HPLC method was calibrated with the corresponding
racemic mixture. The microwave reactions were conducted using a
CEM Discover Explorer Synthesis unit and performed in glass tubes
(capacity 10 mL) sealed with a septum. Temperatures of the reaction
mixtures were monitored by an internal infrared temperature-control
probe.
(2R)-Heptadecane-1,2-diol (6).19a A solution of AD-mix-β (6.00
g) in tert-butanol/water (1:1) (150 mL) was stirred vigorously at room
temperature for 0.5 h. The reaction mixture was cooled to 0 °C, and 1-
heptadecene (5) (1.16 g, 4.86 mmol) was added. The reaction mixture
was then stirred vigorously for 40 h. The reaction was quenched by the
addition of sodium sulﬁte (6.00 g), stirred for 1 h, and extracted with
ethyl acetate (3 × 100 mL). The combined extracts were dried
(Na2SO4) and concentrated to give a solid residue. This was puriﬁed
by dry ﬂash column chromatography using hexane/ethyl acetate (2:1)
(300 mL). Concentration gave (2R)-heptadecane-1,2-diol (6) as a
white solid. Recrystallization from ethyl acetate gave (2R)-
heptadecane-1,2-diol (6) as a crystalline white solid (1.15 g, 87%).
Chiral HPLC (Chiralcel IB column) analysis using 10% isopropanol in
hexane as the elution solvent indicated >99% ee: mp 78−80 °C (lit.19a
mp 77.8−78.2 °C); [α]D23 −1.5 (c 1.0, CHCl3); 1H NMR (400 MHz,
CDCl3) δ 0.88 (t, 3H, J 6.8 Hz), 1.25−1.44 (m, 28H), 1.81 (dd, 1H, J
6.4, 5.2 Hz), 1.95 (d, 1H, J 4.4 Hz), 3.44 (ddd, 1H, J 10.8, 7.6, 5.2 Hz),
3.66 (ddd, 1H, J 10.8, 6.4, 3.2 Hz), 3.68−3.74 (m, 1H); 13C NMR
(101 MHz, CDCl3) δ 14.1 (CH3), 22.7 (CH2), 25.5 (CH2), 29.4 (2 ×
CH2), 29.5 (2 × CH2), 29.6 (3 × CH2), 29.7 (3 × CH2), 31.9 (CH2),
33.3 (CH2), 66.9 (CH2), 72.3 (CH); MS (CI) m/z 273 (MH
+, 3), 255
(100), 237 (5), 123 (5), 69 (6).
(2R)-1-(tert-Butyldimethylsilyloxy)heptadecan-2-ol. A mix-
ture of (2R)-heptadecane-1,2-diol (6) (5.40 g, 19.85 mmol), tert-
butyldimethylsilyl chloride (4.49 g, 29.78 mmol), and imidazole (2.02
g, 29.78 mmol) was dissolved in tetrahydrofuran (300 mL), and the
solution was stirred overnight at room temperature. A white
precipitate was removed by ﬁltration and washed with diethyl ether
(200 mL). The combined ﬁltrate was concentrated and puriﬁed by
ﬂash column chromatography using (diethyl ether/petroleum ether
1:15), which gave (2R)-1-(tert-butyldimethylsilyloxy)heptadecan-2-ol
(7.80 g, 100%) as a colorless oil: IR (NaCl) 3449, 2925, 1464, 1254,
1097, 836, 778 cm−1; [α]D
23 −5.9 (c 1.2, CHCl3); 1H NMR (400 MHz,
CDCl3) δ 0.07 (s, 6H), 0.88 (t, 3H, J 7.2 Hz), 0.91 (s, 9H), 1.24−1.47
(m, 28H), 2.40 (d, 1H, J 3.2 Hz), 3.39 (dd, 1H, J 10.4, 8.4 Hz), 3.59−
3.65 (m, 2H); 13C NMR (101 MHz, CDCl3) δ −5.4 (CH3), −5.3
(CH3), 14.1 (CH3), 18.3 (C), 22.7 (CH2), 25.6 (CH2), 25.9 (3 ×
CH3), 29.4 (CH2), 29.6 (3 × CH2), 29.6 (CH2), 29.7 (3 × CH2), 29.7
(CH2), 31.9 (CH2), 32.8 (CH2), 67.3 (CH2), 71.9 (CH); MS (CI) m/
z 387 (MH+, 100), 369 (49), 329 (19), 295 (3), 111 (2). Anal. Calcd
for C23H50O2Si: C, 71.50; H, 12.95. Found: C, 71.51; H, 13.10.
(2R)-1-(tert-Butyldimethylsilyloxy)-2-(methoxymethoxy)-
heptadecane (7). A solution of (2R)-1-(tert-butyldimethylsilyloxy)-
heptadecan-2-ol (8.59 g, 22.2 mmol) was dissolved in dichloro-
methane (400 mL), and the solution was cooled to 0 °C.
Diisopropylethylamine (11.6 mL, 66.7 mmol) was added followed
by bromomethyl methyl ether (3.72 mL, 45.6 mmol). The solution
was stirred for 0.5 h at 0 °C and then heated under reﬂux overnight.
The reaction mixture was cooled to room temperature, acidiﬁed with
1.0 M hydrochloric acid (15 mL), and extracted with dichloromethane
(3 × 200 mL). After removal of the solvent under reduced pressure,
the resulting material was puriﬁed by ﬂash column chromatography
(petroleum ether/diethyl ether 25:1) to give (2R)-1-(tert-butyldime-
thylsilyloxy)-2-(methoxymethoxy)heptadecane (7) as a colorless oil
(9.48 g, 100%): IR (NaCl) 2923, 1463, 1250, 1105, 1036, 835, 774
cm−1; [α]D
23 +17.1 (c 1.3, CHCl3);
1H NMR (400 MHz, CDCl3) δ 0.05
(s, 6H), 0.85−0.91 (m, 12H), 1.24−1.52 (m, 28H), 3.38 (s, 3H),
3.54−3.64 (m, 3H), 4.65 (d, 1H, J 6.8 Hz), 4.78 (d, 1H, J 6.8 Hz); 13C
NMR (101 MHz, CDCl3) δ −5.4 (CH3), −5.3 (CH3), 14.1 (CH3),
18.3 (C), 22.7 (CH2), 25.4 (CH2), 25.9 (3 × CH3), 29.4 (CH2), 29.6
(3 × CH2), 29.6 (CH2), 29.7 (3 × CH2), 29.7 (CH2), 29.8 (CH2),
31.8 (CH2), 31.9 (CH2), 55.4 (CH3), 65.9 (CH2), 78.3 (CH), 96.3
(CH2); MS m/z 431 (MH
+, 41), 399 (100), 369 (72), 343 (12), 285
(5), 161 (8), 107 (10), 73 (21); HRMS (CI) calcd for C25H55O3Si
(MH+), 431.3920; found, 431.3922.
(2R)-2-(Methoxymethoxy)heptadecane-1-ol (8). A solution of
tetrabutylammonium ﬂuoride (1.0 M in tetrahydrofuran, 22.00 mL,
22.00 mmol) was added to a solution of (2R)-1-(tert-butyldimethylsi-
lyloxy)-2-(methoxymethoxy)heptadecane (7) (7.88 g, 18.32 mmol) in
tetrahydrofuran (400 mL) at 0 °C. The reaction mixture was warmed
to room temperature and stirred overnight. The reaction mixture was
concentrated, and the resulting residue was resuspended in diethyl
ether (200 mL). The solution was washed with water (100 mL), and
the aqueous layer was extracted with diethyl ether (3 × 150 mL). The
combined organic extracts were dried (MgSO4), concentrated, and
puriﬁed by ﬂash column chromatography (petroleum ether/diethyl
ether 7:2) to give (2R)-2-(methoxymethoxy)heptadecane-1-ol (8) as a
white solid (5.91 g, 91%): mp 32−34 °C; IR (NaCl) 2929, 1216, 1032,
753, 667 cm−1; [α]D
23 −27.6 (c 1.2, CHCl3); 1H NMR (400 MHz,
CDCl3) δ 0.88 (t, 3H, J 6.8 Hz), 1.25−1.53 (m, 28H), 3.04 (dd, 1H, J
8.8, 3.6 Hz), 3.43 (s, 3H), 3.46−3.62 (m, 3H), 4.69 (d, 1H, J 6.8 Hz),
4.74 (d, 1H, J 6.8 Hz); 13C NMR (101 MHz, CDCl3) δ 14.1 (CH3),
22.7 (CH2), 25.6 (CH2), 29.4 (2 × CH2), 29.6 (2 × CH2), 29.6 (4 ×
CH2), 29.7 (2 × CH2), 31.7 (CH2), 31.9 (CH2), 55.6 (CH3), 65.7
(CH2), 82.4 (CH), 97.0 (CH2); MS (CI) m/z 317 (MH
+, 9), 285
(93), 255 (80), 181 (2), 139 (3), 97 (4). Anal. Calcd for C19H40O3: C,
72.15; H, 12.65. Found: C, 72.34; H, 12.80.
Ethyl (2E,4R)-4-(Methoxymethoxy)nonadecan-2-enoate (9).
Dimethyl sulfoxide (2.52 mL, 35.6 mmol) was added to a stirred
solution of oxalyl chloride (1.74 mL, 19.93 mmol) in dichloromethane
(350 mL) at −78 °C. The reaction mixture was stirred for 0.3 h before
(2R)-2-(methoxymethoxy)heptadecane-1-ol (8) (4.50 g, 14.24 mmol)
in dichloromethane (50 mL) was slowly added. The reaction mixture
was stirred for an additional 0.3 h before triethylamine (9.90 mL, 71.20
mmol) was added. This reaction mixture was stirred for 0.5 h at −78
°C, allowed to warm to room temperature, and stirred for another 2 h.
Meanwhile, a solution of lithium chloride (1.10 g, 25.63 mmol),
triethyl phosphonoacetate (4.23 mL, 21.36 mmol), and 1,8-
diazabicyclo[5,4,0]undec-7-ene (3.22 mL, 21.36 mmol) in acetonitrile
(350 mL) was prepared and stirred for 1.0 h. The Swern solution was
concentrated in vacuo, the Horner−Wadsworth−Emmons solution
was added, and the reaction mixture was stirred at room temperature
overnight. The reaction was quenched by the addition of a saturated
solution of ammonium chloride (50 mL) and concentrated to give an
orange residue, which was extracted with diethyl ether (4 × 100 mL).
The organic layers were combined, dried (MgSO4), and concentrated
to give an orange oil. Puriﬁcation by ﬂash column chromatography
(diethyl ether/petroleum ether 1:20) gave ethyl (2E,4R)-4-
(methoxymethoxy)nonadecan-2-enoate (9) (5.48 g, 100%) as a yellow
oil: IR (NaCl) 2922, 1723, 1265, 1152, 1030, 921 cm−1; [α]D
23 +40.6 (c
1.2, CHCl3);
1H NMR (400 MHz, CDCl3) δ 0.88 (t, 3H, J 6.8 Hz),
1.25−1.68 (m, 31H), 3.38 (s, 3H), 4.16−4.23 (m, 3H), 4.58 (d, 1H, J
6.8 Hz), 4.63 (d, 1H, J 6.8 Hz), 5.97 (dd, 1H, J 15.6, 1.2 Hz), 6.81 (dd,
1H, J 15.6, 6.4 Hz); 13C NMR (101 MHz, CDCl3) δ 14.1 (CH3), 14.2
(CH3), 22.7 (CH2), 25.2 (CH2), 29.4 (2 × CH2), 29.5 (3 × CH2),
29.6 (3 × CH2), 29.7 (2 × CH2), 31.9 (CH2), 34.9 (CH2), 55.6
(CH3), 60.5 (CH2), 75.3 (CH), 94.6 (CH2), 121.8 (CH), 148.0 (CH),
166.3 (C); MS (CI) m/z 385 (MH+, 11), 355 (33), 323 (100), 283
(47), 173 (12), 109 (4). Anal. Calcd for C23H44O4: C, 71.87; H, 11.45.
Found: C, 71.90; H, 11.68.
(2E,4R)-4-(Methoxymethoxy)nonadecan-2-ene-1-ol (10).
Ethyl (2E,4R)-4-(methoxymethoxy)nonadecan-2-enoate (9) (4.7 g,
12.24 mmol) was dissolved in diethyl ether (350 mL), and the solution
was cooled to −78 °C. DIBAL-H (1 M in hexane, 27 mL, 27.00
mmol) was added dropwise, and the reaction mixture was stirred at
−78 °C for 3 h before warming to room temperature. The solution
was cooled to 0 °C, quenched by the addition of a saturated solution
of ammonium chloride (50 mL), and warmed to room temperature
with vigorous stirring over 1 h, producing a white precipitate. The
The Journal of Organic Chemistry Article
dx.doi.org/10.1021/jo401211j | J. Org. Chem. 2013, 78, 7223−72337227
precipitate was ﬁltered through a pad of Celite and washed with
diethyl ether (400 mL). The ﬁltrate was dried (MgSO4) and
concentrated in vacuo. Flash chromatography (diethyl ether/
petroleum ether 2:5) gave (2E,4R)-4-(methoxymethoxy)nonadecan-
2-ene-1-ol (10) (3.60 g, 86%) as a white solid: mp 38−40 °C; IR
(NaCl) 3390, 2913, 2849, 1471, 1093, 1002, 914, 716 cm−1; [α]D
23
+61.2 (c 1.0, CHCl3);
1H NMR (400 MHz, CDCl3) δ 0.88 (t, 3H, J
6.8 Hz), 1.24−1.62 (m, 29H), 3.37 (s, 3H), 4.02 (q, 1H, J 7.2 Hz),
4.16 (td, 2H, J 5.6, 1.6 Hz), 4.53 (d, 1H, J 6.8 Hz), 4.70 (d, 1H, J 6.8
Hz), 5.57 (ddt, 1H, J 15.6, 7.2, 1.6 Hz), 5.81 (dt, 1H, J 15.6, 5.6 Hz);
13C NMR (101 MHz, CDCl3) δ 14.1 (CH3), 22.7 (CH2), 25.4 (CH2),
29.4 (2 × CH2), 29.6 (3 × CH2), 29.6 (2 × CH2), 29.7 (3 × CH2),
31.9 (CH2), 35.6 (CH2), 55.4 (CH3), 63.0 (CH2), 76.2 (CH), 93.7
(CH2), 131.7 (CH), 131.9 (CH); MS (CI) m/z 343 (MH
+, 3), 319
(11), 281 (81), 263 (14), 157 (8), 113 (7), 85 (100). Anal. Calcd for
C21H42O3: C, 73.68; H, 12.28. Found: C, 73.81; H, 12.47.
(3S,4R)-3-(2′,2′,2′-Trichloromethylcarbonylamino)-4-
(methoxymethoxy)nonadecan-1-ene (12). (2E ,4R)-4-
(Methoxymethoxy)nonadecan-2-ene-1-ol (10) (3.01 g, 8.80 mmol)
was dissolved in dichloromethane (300 mL), and the solution was
cooled to 0 °C. 1,8-Diazabicyclo[5.4.0]undec-7-ene (0.33 mL, 2.20
mmol) was added to the solution followed by trichloroacetonitrile
(1.32 mL, 13.20 mmol). The reaction mixture was warmed to room
temperature, stirred for 2 h, ﬁltered through a short pad of silica gel,
and washed with diethyl ether (200 mL). The resulting ﬁltrate was
concentrated to give allylic trichloroacetimidate 11, which was used
without further puriﬁcation. Resulting allylic trichloroacetimidate 11
was dissolved in toluene (300 mL), and bis(acetonitrile)palladium(II)
chloride (0.22 g, 0.88 mmol) and p-benzoquinone (1.90 g, 17.60
mmol) were added. The reaction mixture was stirred at 45 °C for 24 h,
concentrated, and puriﬁed by ﬂash column chromatography (diethyl
ether/petroleum ether 1:30) to give (3S,4R)-3-(2′,2′,2′-trichlorome-
thylcarbonylamino)-4-(methoxymethoxy)nonadecan-1-ene (12) as a
yellow oil (3.22 g, 78% over 2 steps): IR (NaCl) 3292, 2922, 1717,
1516, 1465, 1236, 1033, 819, 721 cm−1; [α]D
23 −5.1 (c 1.1, CHCl3); 1H
NMR (400 MHz, CDCl3) δ 0.88 (t, 3H, J 6.8 Hz), 1.23−1.65 (m,
28H), 3.43 (s, 3H), 3.56 (ddd, 1H, J 8.4, 4.8, 2.0 Hz), 4.35−4.42 (m,
1H), 4.65 (d, 1H, J 6.8 Hz), 4.74 (d, 1H, J 6.8 Hz), 5.30−5.36 (m,
2H), 5.85 (ddd, 1H, J 17.2, 10.4, 6.8 Hz), 8.28 (br d, 1H, J 7.6 Hz);
13C NMR (101 MHz, CDCl3) δ 14.1 (CH3), 22.7 (CH2), 25.7 (CH2),
29.4 (2 × CH2), 29.5 (3 × CH2), 29.5 (CH2), 29.6 (2 × CH2), 29.7 (2
× CH2), 31.9 (CH2), 33.0 (CH2), 55.9 (CH), 56.7 (CH3), 83.8 (CH),
93.0 (C), 98.1 (CH2), 118.9 (CH2), 131.6 (CH), 161.4 (C); MS (CI)
m/z 486 (MH+, 42), 454 (100), 416 (31), 392 (23), 356 (18), 263
(38), 214 (28), 113 (17), 85 (71). Anal. Calcd for C23H42Cl3NO3: C,
56.79; H, 8.64; N, 2.88. Found: C, 56.87; H, 8.75; N, 2.79.
(2S,3R)-2-(2′,2′,2′-Trichloromethylcarbonylamino)-3-
(methoxymethoxy)octadecan-1-ol (13). (3S,4R)-3-(2′,2′,2′-Tri-
chloromethylcarbonylamino)-4-(methoxymethoxy)nonadecan-1-ene
(12) (1.46 g, 3.00 mmol) was dissolved in a mixture of dichloro-
methane (60 mL) and methanol (20 mL), and the solution was cooled
to −78 °C. Ozone was bubbled through the reaction mixture until the
solution turned slightly blue. After excess ozone was purged with
argon, sodium borohydride (0.11 g, 3.00 mmol) was added in
portions. The solution was stirred for 1.5 h at 0 °C and acidiﬁed with 1
M hydrochloric acid (10 mL). The reaction was quenched by the
addition of water (20 mL) and extracted with diethyl ether (4 × 75
mL). The organic layers were combined, dried (MgSO4), and
concentrated to give an orange oil. Puriﬁcation by ﬂash column
chromatography using (diethyl ether/petroleum ether 1:1) yielded
(2S , 3R ) - 2 - ( 2 ′ , 2 ′ , 2 ′ - t r i c h l o rome thy l c a r bony l am ino) - 3 -
(methoxymethoxy)octadecan-1-ol (13) (1.15 g, 78% over 2 steps) as a
colorless oil: IR (NaCl) 2922, 1705, 1521, 1467, 1030, 819, 822 cm−1;
[α]D
23 −24.4 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 0.88 (t,
3H, J 6.8 Hz), 1.24−1.70 (m, 28H), 2.69 (dd, 1H, J 9.2, 3.4 Hz), 3.43
(s, 3H), 3.70−3.81 (m, 2H), 3.92 (dq, 1H, J 8.4, 3.4 Hz), 4.03 (dt, 1H,
J 12.0, 3.4 Hz), 4.63 (d, 1H, J 6.8 Hz), 4.71 (d, 1H, J 6.8 Hz), 7.96 (br
d, 1H, J 8.4 Hz); 13C NMR (101 MHz, CDCl3) δ 14.1 (CH3), 22.7
(CH2), 25.7 (CH2), 29.4 (2 × CH2), 29.5 (2 × CH2), 29.6 (4 × CH2),
29.7 (CH2), 30.3 (CH2), 31.9 (CH2), 32.9 (CH2), 54.8 (CH), 56.1
(CH3), 61.2 (CH2), 82.5 (CH), 92.7 (C), 97.9 (CH2), 162.2 (C); MS
(CI) m/z 490 (MH+, 21), 458 (18), 428 (12), 372 (100), 340 (22),
255 (5), 137 (6), 73 (16). Anal. Calcd for C22H42Cl3NO4: C, 53.87; H,
8.57; N, 2.85. Found: C, 53.93; H, 8.71; N, 2.95.
(2S,3R)-2-Aminooctadecane-1,3-diol Hydrochloride (2).10c
(2S , 3R ) - 2 - (2 ′ , 2 ′ , 2 ′ -T r i ch lo rome thy l c a rbony l am ino) -3 -
(methoxymethoxy)octadecan-1-ol (13) (0.06 g, 0.12 mmol) was
dissolved in 6 M hydrochloric acid (10 mL), and the solution was
heated at 60 °C for 24 h. The reaction mixture was cooled to room
temperature and washed with diethyl ether (3 × 10 mL). The aqueous
layer was concentrated to give (2R,3S)-2-aminooctadecane-1,3-diol
hydrochloride (2) (0.038 g, 100%) as a colorless oil: IR (NaCl) 3348,
2924, 1600, 1467, 1051 cm−1; [α]D
23 +8.4 (c 3.0, MeOH), lit.10c [α]D
25
+8.1 (c 1.0, MeOH); 1H NMR (400 MHz, CD3OD) δ 0.80 (t, 3H, J
6.8 Hz), 1.17−1.46 (m, 28H), 3.10 (dt, 1H, J 8.6, 4.4 Hz), 3.60 (dd,
1H, J 11.6, 8.6 Hz), 3.65−3.72 (m, 1H), 3.74 (dd, 1H, J 11.6, 4.4 Hz);
13C NMR (101 MHz, CD3OD) δ 14.5 (CH3), 23.8 (CH2), 27.0
(CH2), 30.5 (2 × CH2), 30.6 (3 × CH2), 30.7 (3 × CH2), 30.7 (CH2),
30.8 (CH2), 33.1 (CH2), 34.2 (CH2), 58.5 (CH), 58.9 (CH2), 70.3
(CH); MS (CI) m/z 302 (MH+, 90), 282 (17), 267 (23), 241 (36),
137 (11), 107 (22), 73 (100).
(2S,3R)-1-Methanesulfonate-2-(2′,2′,2′-trichloromethylcar-
bonylamino)-3-(methoxymethoxy)octadecane. A solution of
( 2S , 3R ) - 2 - ( 2 ′ , 2 ′ , 2 ′ - t r i c h l o rome thy l c a r bony l am ino) -3 -
(methoxymethoxy)octadecan-1-ol (13) (1.08 g, 2.20 mmol) was
dissolved in dichloromethane (50 mL). Methanesulfonyl chloride
(0.37 mL, 3.30 mmol), triethylamine (0.67 mL, 4.84 mmol), and 4-
dimethylaminopyridine (0.03 g, 0.22 mmol) were added at 0 °C, and
the solution was stirred at room temperature for 24 h. The reaction
mixture was washed with water (20 mL) and extracted with
dichloromethane (3 × 40 mL). The organic layer was dried
(MgSO4) and concentrated to give the crude product. Puriﬁcation
by ﬂash column chromatography (diethyl ether/petroleum ether 2:3)
gave (2S,3R)-1-methanesulfonate-2-(2′,2′,2′-trichloromethylcarbony-
lamino)-3-(methoxymethoxy)octadecane (1.17 g, 93%) as a colorless
oil: IR (NaCl) 3343, 2916, 1686, 1521, 1349, 1171, 1034, 895 cm−1;
[α]D
23 −22.0 (c 0.9, CHCl3); 1H NMR (400 MHz, CDCl3) δ 0.88 (t,
3H, J 7.2 Hz), 1.24−1.68 (m, 28H), 3.06 (s, 3H), 3.45 (s, 3H), 3.62
(ddd, 1H, J 8.0, 4.6, 2.8 Hz), 4.23−4.29 (m, 1H), 4.34 (dd, 1H, J 10.8,
7.6 Hz), 4.50 (dd, 1H, J 10.8, 4.6 Hz), 4.63 (dd, 1H, J 6.8 Hz), 4.73 (d,
1H, J 6.8 Hz), 8.13 (br d, 1H, J 8.4 Hz); 13C NMR (101 MHz, CDCl3)
δ 14.1 (CH3), 22.7 (CH2), 25.9 (CH2), 29.4 (CH2), 29.4 (2 × CH2),
29.5 (2 × CH2), 29.6 (2 × CH2), 29.7 (CH2), 30.0 (2 × CH2), 31.9
(CH2), 32.9 (CH2), 37.8 (CH3), 53.2 (CH), 56.0 (CH3), 66.4 (CH2),
82.3 (CH), 92.6 (C), 98.2 (CH2), 162.2 (C); MS (CI) m/z 568
(MH+, 4), 536 (10), 502 (8), 474 (20), 438 (100), 404 (89), 370 (31),
356 (21), 241 (9), 137 (15), 97 (19). Anal. Calcd for C23H44Cl3NO6S:
C, 48.59; H, 7.74; N, 2.46. Found: C, 48.64; H, 7.85; N, 2.58.
(2R,3R)-1-Bromo-2-(2′,2′,2′-trichloromethylcarbonylamino)-
3-(methoxymethoxy)octadecane (14). (2S,3R)-1-Methanesulfo-
nate-2-(2′,2′,2′-trichloromethylcarbonylamino)-3-(methoxymethoxy)-
octadecane (0.20 g, 0.35 mmol) was dissolved in dimethyl sulfoxide
(10 mL), and sodium bromide (0.18 g, 1.76 mmol) was added. The
reaction mixture was heated under reﬂux overnight. The reaction
mixture was cooled and concentrated in vacuo. The resulting residue
was dissolved in diethyl ether (20 mL) and washed with water (2 × 30
mL). The organic layer was dried and concentrated in vacuo.
Puriﬁcation by column chromatography (petroleum ether/diethyl
ether 14:1) gave (2R,3R)-1-bromo-2-(2′,2′,2′-trichloromethylcarbony-
lamino)-3-(methoxymethoxy)octadecane (14) (0.14 g, 73%) as a
colorless oil: IR (NaCl) 3330, 2921, 1718, 1517, 1030, 819 cm−1; [α]D
23
+30.3 (c 1.0, CHCl3);
1H NMR (400 MHz, CDCl3) δ 0.88 (t, 3H, J
6.8 Hz), 1.25−1.62 (m, 28H), 3.44 (s, 3H), 3.57 (dd, 1H, J 11.2, 7.6
Hz), 3.63−3.68 (m, 2H), 4.26 (ddt, 1H, J 9.2, 7.6, 4.0 Hz), 4.65 (d,
1H, J 6.8 Hz), 4.73 (d, 1H, J 6.8 Hz), 7.69 (br d, 1H, J 9.2 Hz); 13C
NMR (101 MHz, CDCl3) δ 14.1 (CH3), 22.7 (CH2), 25.4 (CH2),
29.4 (2 × CH2), 29.5 (2 × CH2), 29.5 (CH2), 29.6 (2 × CH2), 29.7 (2
× CH2), 29.7 (CH2), 31.4 (CH2), 31.9 (CH2), 32.4 (CH2), 54.6
(CH), 56.0 (CH3), 81.6 (CH), 92.7 (C), 97.8 (CH2), 161.8 (C); MS
m/z 552 (MH+, 10), 522 (71), 492 (38), 472 (16), 438 (24), 285
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(100), 239 (33), 189 (12), 151 (12), 117 (11); HRMS (CI) calcd for
C22H42
79Br35Cl3NO3 (MH
+), 552.1414; found, 552.1416.
(2S,3R)-2-Acetylamino-3-(methoxymethoxy)octadecane
(15). To a solution of (2R,3R)-1-bromo-2-(2′,2′,2′-trichloromethyl-
carbonylamino)-3-(methoxymethoxy)octadecane (14) (0.02g, 0.04
mmol) in methanol (5 mL) was added 10% palladium on carbon
(0.03 g) and triethylamine (0.03 mL, 0.21 mmol). The reaction
mixture was allowed to stir under an atmosphere of hydrogen at room
temperature for 18 h. The reaction mixture was ﬁltered through a
short pad of Celite, which was washed with methanol (50 mL) and
concentrated in vacuo. Puriﬁcation by ﬂash column chromatography
(petroleum ether/diethyl ether 1:6) gave (2S,3R)-2-acetylamino-3-
(methoxymethoxy)octadecane (15) (0.01 g, 68%) as a white solid: mp
35−37 °C; IR (NaCl) 3370, 2925, 1647, 1540, 1372, 1034, 920 cm−1;
[α]D
23 −45.3 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 0.81 (t,
3H, J 6.4 Hz), 1.02 (d, 3H, J 6.8 Hz), 1.18−1.51 (m, 28H), 1.93 (s,
3H), 3.35−3.38 (m, 4H), 3.90−3.97 (m, 1H), 4.55 (d, 1H, J 6.8 Hz),
4.65 (d, 1H, J 6.8 Hz), 6.69 (br s, 1H); 13C NMR (101 MHz, CDCl3)
δ 13.9 (CH3), 14.1 (CH3), 22.7 (CH2), 23.5 (CH3), 25.9 (CH2), 29.3
(CH2), 29.5 (2 × CH2), 29.5 (4 × CH2), 29.6 (2 × CH2), 29.7 (CH2),
31.9 (CH2), 32.7 (CH2), 47.2 (CH), 55.7 (CH3), 84.4 (CH), 98.1
(CH2), 169.1 (C); MS m/z 372 (MH
+, 100), 340 (31), 310 (4), 174
(3), 113 (4), 71 (10); HRMS (CI) calcd for C22H46NO3 (MH
+),
372.3478; found, 372.3475.
(2S,3R)-2-Aminooctadecan-3-ol Hydrochloride (4).11g
(2S,3R)-2-Acetylamino-3-(methoxymethoxy)octadecane (15) (0.01 g,
0.03 mmol) was dissolved in 6 M hydrochloric acid (1.5 mL), and the
solution was heated at 60 °C for 48 h. The reaction mixture was
cooled and washed with diethyl ether (3 × 10 mL). The aqueous layer
was concentrated to give (2S,3R)-2-aminooctadecan-3-ol hydro-
chloride (4) (0.008 g, 100%) as a white solid: mp 64−66 °C; [α]D23
+7.5 (c 0.3, MeOH), lit.11g [α]D
25 +7.15 (c 0.42, MeOH); 1H NMR
(400 MHz, CD3OD) δ 0.80 (t, 3H, J 5.6 Hz), 1.12 (d, 3H, J 5.2 Hz),
1.19−1.35 (m, 28H), 3.14−3.20 (m, 1H), 3.57−3.62 (m, 1H); 13C
NMR (101 MHz, CD3OD) δ 12.1 (CH3), 14.5 (CH3), 23.8 (CH2),
27.0 (CH2), 30.5 (CH2), 30.7 (CH2), 30.7 (2 × CH2), 30.8 (4 ×
CH2), 30.8 (2 × CH2), 33.1 (CH2), 34.0 (CH2), 52.6 (CH), 71.7
(CH); MS (CI) m/z 286 (MH+, 100), 268 (16), 241 (8), 197 (12),
113 (100), 85 (41).
2,3-Isopropylidine-1-methoxy-D-ribofuranoside (17).23 Con-
centrated hydrochloric acid (34−36%, 0.02 mL) was added to a stirred
solution of D-ribose (16) (0.20 g, 1.34 mmol) in acetone (3 mL) and
methanol (3 mL). The solution was heated under reﬂux for 2 h and
cooled to room temperature. The reaction was neutralized by the
addition of a saturated solution of sodium hydrogen carbonate (10
mL) and extracted with ethyl acetate (2 × 50 mL). The organic layers
were combined and washed with water (40 mL) and brine (40 mL),
dried (MgSO4), and concentrated in vacuo to yield 2,3-isopropylidine-
1-methoxy-D-ribofuranoside (17) (0.23 g, 84%) as a colorless oil (the
spectroscopic data were as reported in the literature23): [α]D
25 −52.8 (c
1.0, CHCl3);
1H NMR (400 MHz, CDCl3) δ 1.32 (s, 3H), 1.48 (s,
3H), 3.24 (dd, 1H, J 10.5, 2.7 Hz), 3.43 (s, 3H), 3.61 (ddd, 1H, J 12.8,
10.5, 2.7 Hz), 3.70 (dt, 1H, J 12.8, 2.7 Hz), 4.43 (t, 1H, J 2.7 Hz), 4.59
(d, 1H, J 5.9 Hz), 4.84 (d, 1H, J 5.9 Hz), 4.97 (s, 1H); 13C NMR (101
MHz, CDCl3) δ 24.7 (CH3), 26.3 (CH3), 55.5 (CH3), 64.0 (CH2),
81.5 (CH), 85.8 (CH), 88.4 (CH), 110.0 (CH), 112.1 (C); MS (CI)
m/z 205 (MH+, 14), 173 (100), 113 (5), 85 (10), 69 (14).
5-Deoxy-5-iodo-2,3-isopropylidine-1-methoxy-D-ribofura-
noside (18).31 Iodine (0.34 g, 1.34 mmol) was added to a stirred
solution of 2,3-isopropylidine-1-methoxy-D-ribofuranoside (17) (0.23
g, 1.12 mmol), imidazole (0.11 g, 1.68 mmol), and triphenylphosphine
(0.35 g, 1.34 mmol) in toluene (15 mL) and acetonitrile (5 mL). The
solution was heated under reﬂux for 0.1 h and cooled to room
temperature. Iodine was added in 10 mg portions until the solution
remained dark-brown. The solution was diluted with diethyl ether (40
mL) and washed with a saturated solution of sodium thiosulfate (80
mL), water (100 mL), and brine (70 mL). The organic layer was dried
(MgSO4), concentrated in vacuo, and ﬁltered through a short plug of
silica (ethyl acetate/petroleum ether 1:20) to yield 5-deoxy-5-iodo-2,3-
isopropylidine-1-methoxy-D-ribofuranoside (18) (0.33 g, 94%) as a
colorless oil: [α]D
25 −65.7 (c 1.0, CHCl3), lit.31 [α]D25 −68.3 (c 0.1,
CHCl3);
1H NMR (400 MHz, CDCl3) δ 1.33 (d, 3H, J 0.4 Hz), 1.48
(d, 3H, J 0.4 Hz), 3.16 (t, 1H, J 10.0 Hz), 3.29 (dd, 1H, J 10.0, 6.0
Hz), 3.37 (s, 3H), 4.44 (ddd, 1H, J 10.0, 6.0, 0.7 Hz), 4.63 (d, 1H, J
5.9 Hz), 4.76 (dd, 1H, J 5.9, 0.7 Hz), 5.05 (s, 1H); 13C NMR (101
MHz, CDCl3) δ 6.8 (CH2), 25.2 (CH3), 26.6 (CH3), 55.4 (CH3), 83.2
(CH), 85.5 (CH), 87.6 (CH), 109.9 (CH), 112.8 (C); MS (CI) m/z
315 (MH+, 8), 279 (7), 127 (8), 113 (38), 85 (52), 73 (100).
(2S,3R)-2,3-(O-Isopropylidene)pent-4-ene-1,2,3-triol (20).32
Zinc (2.44 g, 35.66 mmol) was added to a solution of 5-deoxy-5-
iodo-2,3-isopropylidine-1-methoxy-D-ribofuranoside (18) (2.24 g, 7.14
mmol) and a catalytic amount of glacial acetic acid (12 drops) in
methanol (40 mL). The suspension was heated under reﬂux for 1 h
and cooled to 0 °C. A saturated solution of sodium borohydride in
ethanol (140 mL) was added dropwise with stirring to the reaction
mixture, stirred at 0 °C for 0.5 h, and warmed to room temperature
over 3 h. The mixture was concentrated in vacuo. The resulting
residue was dissolved in diethyl ether (50 mL) and ﬁltered through
Celite. The organic layer was washed with water (2 × 50 mL) and
brine (2 × 50 mL), dried (MgSO4), and concentrated in vacuo to yield
(2S,3R)-2,3-(O-isopropylidene)pent-4-ene-1,2,3-triol (20) (1.01 g,
89%) as a colorless oil: [α]D
25 −40.0 (c 1.5, CHCl3), lit.32 [α]D24
−45.7 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.40 (d, 3H, J
0.4 Hz), 1.51 (d, 3H, J 0.4 Hz), 1.81 (t, 1H, J 6.2 Hz), 3.59 (dd, 2H, J
6.2, 5.9 Hz), 4.26 (dt, 1H, J 6.6, 5.9 Hz), 4.65 (tt, 1H, J 6.6, 1.1 Hz),
5.28 (ddd, 1H, J 10.3, 1.5, 1.1 Hz), 5.40 (ddd, 1H, J 17.5, 1.5, 1.1 Hz),
5.87 (ddd, 1H, J 17.5, 10.3, 6.6 Hz); 13C NMR (101 MHz, CDCl3) δ
25.3 (CH3), 27.8 (CH3), 62.1 (CH2), 78.3 (CH), 78.4 (CH), 108.9
(C), 119.0 (CH2), 133.1 (CH); MS (CI) m/z 159 (MH
+, 71), 141
(11), 101 (100), 83 (12).
(2S,3R)-2,3-(O-Isopropylidene)heptadecane-1,2,3-triol (22).
A solution of Grubbs second-generation catalyst (0.14 g, 0.17
mmol) in dichloromethane (20 mL) was added to a solution of
(2S,3R)-2,3-(O-isopropylidene)pent-4-ene-1,2,3-triol (20) (0.54 g,
3.41 mmol) and 1-tetradecene (1.01 g, 5.12 mmol) in dichloro-
methane (20 mL) and heated under reﬂux for 16 h. The reaction
mixture was then concentrated in vacuo and ﬁltered through a plug of
silica ﬁrst with petroleum ether (500 mL) followed by 25% ethyl
acetate in petroleum ether (1000 mL). The second wash was
concentrated in vacuo to yield cross metathesis product 21 as a clear
oil, which was used without further puriﬁcation. Alkene 21 was
dissolved in ethyl acetate (40 mL), and a suspension of 10% palladium
on carbon (0.16 g, 30% w/w) in ethyl acetate (10 mL) was added. The
mixture was degassed, purged with hydrogen gas, and left to stir at
room temperature under a hydrogen atmosphere for 2 h. The
suspension was ﬁltered through Celite with ethyl acetate (100 mL)
and puriﬁed by column chromatography (ethyl acetate/petroleum
ether 1:5) to yield (2S,3R)-2,3-(O-isopropylidene)heptadecane-1,2,3-
triol (22) (0.92 g, 82% over two steps) as a colorless oil: IR (neat)
3437, 2923, 2854, 1466, 1379, 1217, 1042 cm−1; [α]D
24 −10.4 (c 1.0,
CHCl3);
1H NMR (400 MHz, CDCl3) δ 0.87 (t, 3H, J 6.8 Hz), 1.21−
1.53 (m, 32H), 1.95 (br s, 1H), 3.55−3.63 (m, 2H), 4.10−4.19 (m,
2H); 13C NMR (101 MHz, CDCl3) δ 14.3 (CH3), 22.8 (CH2), 25.7
(CH3), 26.8 (CH3), 28.4 (CH2), 29.0 (CH2), 29.5 (CH2), 29.6 (CH2),
29.7 (CH2), 29.8 (3 × CH2), 29.8 (2 × CH2), 29.8 (CH2), 32.1
(CH2), 62.0 (CH2), 77.2 (CH), 78.1 (CH), 108.2 (C); MS m/z 329
(MH+, 100), 313 (13), 271 (60), 253 (10), 235 (5), 159 (3), 69 (7);
HRMS (CI) calcd for C20H41O3 (MH
+), 329.3056; found, 329.3051.
Ethyl (2E,4S,5R)-4,5-(O-Isopropylidene)-4,5-dihydroxynona-
dec-2-enoate (23). Dimethyl sulfoxide (0.68 g, 8.66 mmol) was
added to a stirred solution of oxalyl chloride (0.56 g, 4.34 mmol) in
dichloromethane (15 mL) at −78 °C. The reaction mixture was stirred
for 0.3 h, and (2S,3R)-2,3-(O-isopropylidene)heptadecane-1,2,3-triol
(22) (0.95 g, 2.89 mmol) in dichloromethane (15 mL) was slowly
added. The mixture was stirred for an additional 0.3 h, and
triethylamine (1.46 g, 14.44 mmol) was added. This reaction mixture
was stirred for 0.5 h at −78 °C and warmed to room temperature for a
further 2 h. Meanwhile, a solution of lithium chloride (0.24 g, 5.78
mmol), triethyl phosphonoacetate (0.75 g, 4.91 mmol), and 1,8-
diazabicyclo[5.4.0]undec-7-ene (1.10 g, 4.91 mmol) in acetonitrile (30
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mL) was prepared and stirred for 1.0 h. The Swern solution was
concentrated in vacuo and the Horner−Wadsworth−Emmons
solution was added. The reaction mixture was stirred at room
temperature overnight, quenched by the addition of a saturated
solution of ammonium chloride (20 mL), and concentrated to give an
orange residue that was extracted with diethyl ether (2 × 30 mL). The
organic layers were combined, washed with water (50 mL) and brine
(50 mL), dried (MgSO4), and concentrated to give a yellow oil.
Puriﬁcation by ﬁltration through a pad of silica (ethyl acetate/
petroleum ether 1:5) gave ethyl (2E,4S,5R)-4,5-(O-isopropylidene)-
4,5-dihydroxynonadec-2-enoate (23) (0.95 g, 83%) as a clear yellow
oil: IR (neat) 2924, 2853, 1722, 1466, 1370, 1252, 1161, 1038 cm−1;
[α]D
26 −5.1 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 0.88 (t,
3H, J 6.9 Hz), 1.23−1.33 (m, 27H), 1.35−1.49 (m, 8H), 4.16−4.26
(m, 3H), 4.63 (td, 1H, J 6.3, 1.4 Hz), 6.06 (dd, 1H, J 15.6, 1.4 Hz),
6.84 (dd, 1H, J 15.6, 6.3 Hz); 13C NMR (101 MHz, CDCl3) δ 14.3
(CH3), 14.4 (CH3), 22.8 (CH2), 25.7 (CH3), 26.5 (CH2), 28.2 (CH3),
29.5 (CH2), 29.6 (CH2), 29.7 (CH2), 29.7 (CH2), 29.8 (CH2), 29.8 (2
× CH2), 29.8 (2 × CH2), 30.6 (CH2), 32.1 (CH2), 60.6 (CH2), 77.6
(CH), 78.7 (CH), 108.9 (C), 123.2 (CH), 144.0 (CH), 166.2 (C);
MS (CI) m/z 397 (MH+, 88), 379 (12), 339 (100), 293 (8), 143 (13),
81 (12). Anal. Calcd for C24H44O4: C, 72.68; H, 11.18. Found: C,
72.48; H, 11.29.
(2E,4S,5R)-4,5-(O-Isopropylidene)nonadec-2-ene-1,4,5-triol
(24). Diisobutylaluminium hydride (0.55 mL, 5.50 mmol, 1 M in
hexanes) was added dropwise to a stirred solution of ethyl (2E,4S,5R)-
4,5-(O-isopropylidene)-4,5-dihydroxynonadec-2-enoate (23) (0.95 g,
2.39 mmol) in diethyl ether (50 mL) at −78 °C. The solution was
stirred at −78 °C for 3 h and warmed to room temperature over 18 h.
The reaction mixture was quenched with a saturated solution of
ammonium chloride (30 mL), ﬁltered through a pad of Celite, and
extracted with diethyl ether (30 mL). The organic layer was washed
with water (50 mL) and brine (50 mL). The organic layer was dried
(MgSO4) and concentrated in vacuo to give a colorless oil. Puriﬁcation
by column chromatography (ethyl acetate/petroleum ether 1:5) gave
(2E,4S,5R)-4,5-(O-isopropylidene)nonadec-2-ene-1,4,5-triol (24)
(0.71 g, 83%) as a colorless oil: IR (neat) 3417, 2922, 2853, 1456,
1369, 1216, 1095, 1027, 974 cm−1; [α]D
24 −42.0 (c 1.1, CHCl3); 1H
NMR (500 MHz, CDCl3) δ 0.87 (t, 3H, J 7.0 Hz), 1.22−1.52 (m,
32H), 1.62 (br s, 1H), 4.12 (ddd, 1H, J 8.7, 6.3, 4.7 Hz), 4.16 (dd, 2H,
J 5.2, 1.5 Hz), 4.50 (dd, 1H, J 7.9, 6.3 Hz), 5.68 (ddt, 1H, J 15.5, 7.9,
1.5 Hz), 5.88 (dtd, 1H, J 15.5, 5.2, 0.6 Hz); 13C NMR (126 MHz,
CDCl3) δ 14.2 (CH3), 22.8 (CH2), 25.8 (CH3), 26.4 (CH2), 28.4
(CH3), 29.5 (CH2), 29.7 (CH2), 29.7 (CH2), 29.8 (CH2), 29.8 (2 ×
CH2), 29.8 (3 × CH2), 30.5 (CH2), 32.1 (CH2), 63.0 (CH2), 78.5
(CH), 79.1 (CH), 108.2 (C), 127.5 (CH), 133.5 (CH); MS m/z 355
(MH+, 26), 337 (20), 297 (41), 279 (100), 251 (23), 225 (90), 111
(69), 73 (71); HMRS (CI) calcd for C22H43O3 (MH
+), 355.3212;
found, 355.3211.
(3R,4S,5R)-3-(2′,2′,2′-Trichloromethylcarbonylamino)-4,5-
(O-isopropylidene)nonadec-1-ene-4,5-diol (26) and (3S,4S,5R)-
3 - (2 ′ ,2 ′ ,2 ′ -Tr ich loromethy lcarbony lamino) -4 ,5 - (O -
isopropylidene)nonadec-1-ene-4,5-diol (27). 1,8-Diazabicycloun-
dec-7-ene (0.07 g, 0.49 mmol) was added to a stirred solution of
(2E,4S,5R)-4,5-(O-isopropylidene)nonadec-2-en-1,4,5-triol (24) (0.19
g, 0.54 mmol) and trichloroacetonitrile (0.12 g, 0.82 mmol) at 0 °C in
dichloromethane (30 mL). The solution was stirred at 0 °C for 0.5 h
and warmed to room temperature over 3 h. The reaction mixture was
ﬁltered through a pad of silica with dichloromethane (200 mL) and
concentrated in vacuo to yield crude allylic trichloroacetimidate 25,
which was used without further puriﬁcation. Allylic trichloroacetimi-
date 25 was dissolved in p-xylene (4 mL), and the solution was added
to a pressure tube loaded with a stirrer bar and potassium carbonate
(0.01 g, 0.72 mmol). The tube was sealed under argon and heated with
stirring at 160 °C for 60 h. The reaction mixture was cooled and
ﬁltered through Celite to yield a yellow viscous oil. Puriﬁcation by
column chromatography (ethyl acetate/petroleum ether 1:20) gave
(3R,4S,5R)-3-(2′,2′,2′-trichloromethylcarbonylamino)-4,5-(O-
isopropylidene)nonadec-1-ene-4,5-diol (26) (0.12 g, 44%) as a
colorless oil followed by (3S,4S,5R)-3-(2′,2′,2′-trichloromethylcarbo-
nylamino)-4,5-(O-isopropylidene)nonadec-1-ene-4,5-diol (27) (0.07
g, 26%) as a colorless oil. For 26: IR (neat) 3427, 2922, 2853, 1721,
1496, 1211, 819 cm−1; [α]D
27 −10.5 (c 1.4, CHCl3); 1H NMR (500
MHz, CDCl3) δ 0.88 (t, 3H, J 7.0 Hz), 1.22−1.33 (m, 24H), 1.38 (s,
3H), 1.46−1.58 (m, 5H), 4.21−4.27 (m, 2H), 4.37−4.42 (m, 1H),
5.27 (d, 1H, J 10.4 Hz), 5.30 (d, 1H, J 17.1 Hz), 5.83 (ddd, 1H, J 17.1,
10.4, 5.8 Hz), 7.19 (d, 1H, J 7.7 Hz); 13C NMR (126 MHz, CDCl3) δ
14.3 (CH3), 22.9 (CH2), 24.3 (CH3), 27.2 (CH3), 27.3 (CH2), 29.4
(CH2), 29.5 (CH2), 29.6 (CH2), 29.6 (CH2), 29.7 (2 × CH2), 29.8 (2
× CH2), 29.8 (CH2), 29.8 (CH2), 32.1 (CH2), 53.2 (CH), 77.6 (CH),
78.4 (CH), 92.9 (C), 108.1 (C), 117.2 (CH2), 134.8 (CH), 160.8 (C);
MS m/z 498 (MH+, 14), 440 (31), 406 (28), 297 (18), 161 (35), 113
(52), 73 (100); HRMS (CI) calcd for C24H43
35Cl3NO3 (MH
+),
498.2309; found, 498.2307. For 27: IR (neat) 3324, 2922, 2853, 1694,
1515, 1370, 1217, 1056, 822 cm−1; [α]D
27 −48.0 (c 0.8, CHCl3); 1H
NMR (500 MHz, CDCl3) δ 0.88 (t, 3H, J 7.0 Hz), 1.24−1.33 (m,
24H), 1.36 (s, 3H), 1.48 (s, 3H), 1.50−1.64 (m, 2H), 4.13 (dd, 1H, J
6.3, 3.8 Hz), 4.23 (ddd, 1H, J 9.7, 6.3, 3.8 Hz), 4.55 (dddt, 1H, J 8.7,
5.2, 3.8, 1.7 Hz), 5.26−5.33 (m, 2H), 6.00 (ddd, 1H, J 17.4, 10.5, 5.2
Hz), 6.92 (d, 1H, J 8.7 Hz); 13C NMR (126 MHz, CDCl3) δ 14.3
(CH3), 22.8 (CH2), 25.3 (CH3), 27.0 (CH3), 27.1 (CH2), 29.0 (CH2),
29.5 (CH2), 29.6 (CH2), 29.7 (CH2), 29.7 (CH2), 29.8 (CH2), 29.8 (2
× CH2), 29.8 (CH2), 29.9 (CH2), 32.1 (CH2), 54.2 (CH), 77.6 (CH),
79.0 (CH), 92.8 (C), 108.7 (C), 118.0 (CH2), 134.0 (CH), 161.2 (C);
MS m/z 498 (MH+, 5), 464 (13), 440 (100), 406 (81), 394 (22), 329
(21), 297 (20), 271 (9), 113 (7), 73 (12); HRMS (CI) calcd for
C24H43
35Cl3NO3 (MH
+), 498.2309; found, 498.2304.
(3E,5S,6R)-5,6-(O-Isopropylidene)-5,6-dihydroxyicos-3-en-2-
one (28). Dimethyl sulfoxide (0.68 g, 8.66 mmol) was added to a
stirred solution of oxalyl chloride (0.56 g, 4.34 mmol) in dichloro-
methane (15 mL) at −78 °C. The reaction mixture was stirred for 0.3
h, and (2S,3R)-2,3-(O-isopropylidene)heptadecane-1,2,3-triol (22)
(0.95 g, 2.89 mmol) in dichloromethane (15 mL) was slowly added.
The mixture was stirred for an additional 0.3 h, and triethylamine
(1.46 g, 14.44 mmol) was added. This reaction mixture was stirred for
0.5 h at −78 °C, allowed to warm to room temperature, and stirred for
a further 2 h. Meanwhile, a solution of lithium chloride (0.24 g, 5.78
mmol), dimethyl 2-oxopropylphosphonate (0.82 g, 4.91 mmol), and
1,8-diazabicyclo[5.4.0]undec-7-ene (1.10 g, 4.91 mmol) in acetonitrile
(30 mL) was prepared and stirred for 1.0 h. The Swern solution was
concentrated in vacuo, and the Horner−Wadsworth−Emmons
solution was added. The reaction mixture was stirred at room
temperature overnight, quenched by the addition of a saturated
solution of ammonium chloride (20 mL), and concentrated to give an
orange residue that was extracted with diethyl ether (2 × 30 mL). The
organic layers were combined, washed with water (50 mL) and brine
(50 mL), dried (MgSO4), and concentrated to give a yellow oil.
Puriﬁcation by ﬁltration through a pad of silica (ethyl acetate/
petroleum ether 1:5) gave (3E,5S,6R)-5,6-(O-isopropylidene)-5,6-
dihydroxyicos-3-en-2-one (28) (0.84 g, 79%) as a colorless oil: IR
(neat) 2916, 2848, 1697, 1676, 1632, 1373, 1246, 1217, 1102, 1036
cm−1; [α]D
21 −2.3 (c 1.3, CHCl3); 1H NMR (400 MHz, CDCl3) δ 0.87
(t, 3H, J 6.9 Hz), 1.21−1.34 (m, 24H), 1.38 (s, 3H), 1.41−1.49 (m,
2H), 1.51 (s, 3H), 2.28 (s, 3H), 4.23 (ddd, 1H, J 8.7, 6.4, 4.6 Hz), 4.64
(td, 1H, J 6.4, 1.3 Hz), 6.28 (dd, 1H, J 15.9, 1.3 Hz), 6.65 (dd, 1H, J
15.9, 6.4 Hz); 13C NMR (101 MHz, CDCl3) δ 14.3 (CH3), 22.8
(CH2), 25.6 (CH3), 26.4 (CH2), 27.7 (CH3), 28.2 (CH3), 29.5 (CH2),
29.6 (CH2), 29.7 (CH2), 29.7 (CH2), 29.8 (CH2), 29.8 (2 × CH2),
29.8 (2 × CH2), 30.7 (CH2), 32.1 (CH2), 77.8 (CH), 78.6 (CH),
109.0 (C), 131.9 (CH), 142.6 (CH), 198.0 (C); MS m/z 367 (MH+,
71), 349 (17), 309 (45), 239 (4), 141 (100), 113 (16), 81 (16);
HRMS (CI) calcd for C23H43O3 (MH
+), 367.3212; found, 367.3216.
(2S,3E,5S,6R)-5,6-(O-Isopropylidene)icos-3-ene-2,5,6-triol
(29). (R)-(+)-2-Methyl-CBS-oxazaborolidine (0.60 mL, 0.60 mmol, 1
M solution in toluene) was added dropwise with stirring to a solution
of (3E,5S,6R)-5,6-(O-isopropylidene)-5,6-dihydroxyicos-3-en-2-one
(28) (0.20 g, 0.55 mmol) in dry tetrahydrofuran (20 mL) at 0 °C.
The solution was stirred for 0.5 h at 0 °C, borane (1.64 mL, 1.64
mmol, 1 M in tetrahydrofuran) was added dropwise, and stirring was
continued at 0 °C for 7.5 h. The reaction was quenched with methanol
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(10 mL), warmed to room temperature, and concentrated in vacuo.
The resulting residue was dissolved in diethyl ether (30 mL) and
washed with 1 M citric acid (3 × 50 mL), water (50 mL), and brine
(50 mL). The organic layer was dried (MgSO4) and puriﬁed by
column chromatography (ethyl acetate/petroleum ether 1:6, 1%
triethylamine) to yield (2S,3E,5S,6R)-5,6-(O-isopropylidene)icos-3-
ene-2,5,6-triol (29) (0.20 g, 99%) as a colorless oil: IR (neat) 3397,
2982, 2922, 1456, 1368, 1215, 1032 cm−1; [α]D
22 +4.5 (c 1.1, CHCl3);
1H NMR (500 MHz, CDCl3) δ 0.88 (t, 3H, J 7.0 Hz), 1.23−1.32 (m,
27H), 1.36 (s, 3H), 1.38−1.53 (m, 5H), 4.12 (ddd, 1H, J 8.6, 6.3, 4.7
Hz), 4.35 (quin, 1H, J 5.9 Hz), 4.49 (dd, 1H, J 7.9, 6.3 Hz), 5.65 (ddd,
1H, J 15.5, 7.9, 1.2 Hz), 5.81 (ddd, 1H, J 15.5, 5.9, 0.7 Hz); 13C NMR
(126 MHz, CDCl3) δ 14.3 (CH3), 22.8 (CH2), 23.4 (CH3), 25.8
(CH3), 26.3 (CH2), 28.4 (CH3), 29.5 (CH2), 29.7 (CH2), 29.7 (CH2),
29.8 (CH2), 29.8 (2 × CH2), 29.8 (CH2), 29.8 (2 × CH2), 30.6
(CH2), 32.1 (CH2), 68.2 (CH), 78.5 (CH), 79.0 (CH), 108.2 (C),
125.9 (CH), 138.4 (CH); HRMS (ESI) calcd for C23H44NaO3
(MNa+), 391.3183; found, 391.3169.
(2R,3E,5S,6R)-5,6-(O-Isopropylidene)icos-3-ene-2,5,6-triol
(30). The reaction was carried out according to the procedure
described above using (3E,5S,6R)-5,6-(O-isopropylidene)-5,6-dihy-
droxyicos-3-ene-2-one (28) (0.10 g, 0.28 mmol) and (S)-(−)-2-
methyl-CBS-oxazaborolidine (0.30 mL, 0.30 mmol, 1 M solution in
tetrahydrofuran), yielding (2R,3E,5S,6R)-5,6-(O-isopropylidene)icos-
3-en-2,5,6-triol (30) (0.065 g, 64%) as a colorless oil: IR (neat) 3414,
2922, 2853, 1458, 1370, 1217, 1044, 756 cm−1; [α]D
24 −3.7 (c 1.0,
CHCl3);
1H NMR (500 MHz, CDCl3) δ 0.88 (t, 3H, J 6.9 Hz), 1.20−
1.31 (m, 27H), 1.35 (s, 3H), 1.38−1.48 (s, 5H), 4.08−4.15 (m, 1H),
4.33 (quintet of doublets, 1H, J 6.5, 0.9 Hz), 4.47 (dd, 1H, J 8.0, 6.2
Hz), 5.62 (ddd, 1H, J 15.5, 8.0, 0.9 Hz), 5.78 (ddd, 1H, J 15.5, 6.5, 0.6
Hz); 13C NMR (126 MHz, CDCl3) δ 14.3 (CH3), 22.8 (CH2), 23.3
(CH3), 25.8 (CH3), 26.2 (CH2), 28.4 (CH3), 29.5 (CH2), 29.7 (CH2),
29.7 (CH2), 29.8 (3 × CH2), 29.8 (CH2), 29.8 (CH2), 30.4 (CH2),
30.5 (CH2), 32.1 (CH2), 68.3 (CH), 78.5 (CH), 79.0 (CH), 108.2
(C), 126.1 (CH), 138.5 (CH); MS m/z 369 (MH+, 21), 351 (37), 309
(14), 293 (100), 225 (28), 183 (39), 125 (88); HRMS (CI) calcd for
C23H45O3 (MH
+), 369.3369; found, 369.3366.
(2E,4S,5S,6R)-4-(2′,2′,2′-Trichloromethylcarbonylamino)-
5,6-(O-isopropylidene)icos-2-ene-5,6-diol (31). 1,8-Diazabicy-
cloundec-7-ene (0.011 g, 0.07 mmol) was added to a stirred solution
of (2S,3E,5S,6R)-5,6-(O-isopropylidene)icos-3-ene-2,5,6-triol (29)
(0.053 g, 0.14 mmol) and trichloroacetonitrile (0.031 g, 0.21 mmol)
at 0 °C in dichloromethane (3 mL). The solution was stirred at 0 °C
for 0.5 h and warmed to room temperature over 3 h. The solution was
ﬁltered through a pad of silica with dichloromethane (200 mL) and
concentrated in vacuo to yield the allylic trichloroacetimidate as a
yellow oil, which was used without further puriﬁcation. The allylic
trichloroacetimidate was dissolved in p-xylene (2 mL) and added to a
microwave vial loaded with a silicon carbide bar and potassium
carbonate (0.012 g, 6 mg/mL). The vial was sealed under argon and
heated at 140 °C for 0.25 h in a microwave reactor. After the reaction
was cooled to room temperature, the reaction mixture was
concentrated in vacuo. Puriﬁcation by column chromatography
(diethyl ether/petroleum ether 1:10) gave (2E,4S,5S,6R)-4-(2′,2′,2′-
trichloromethylcarbonylamino)-5,6-(O-isopropylidene)icos-2-ene-5,6-
diol (31) (0.053 g, 72%) as a white solid: mp 53−58 °C; IR (neat)
3356, 2918, 2851, 1688, 1516, 1219, 959, 818 cm−1; [α]D
22 −28.5 (c
1.0, CHCl3);
1H NMR (500 MHz, CDCl3) δ 0.88 (t, 3H, J 6.9 Hz),
1.23−1.38 (m, 27H), 1.48 (s, 3H), 1.57−1.69 (m, 2H), 1.72 (dd, 3H, J
6.4, 1.4 Hz), 4.11 (dd, 1H, J 6.3, 3.8 Hz), 4.21 (ddd, 1H, J 9.6, 6.3, 3.7
Hz), 4.47−4.51 (m, 1H), 5.60 (ddd, 1H, J 15.5, 5.7, 1.4 Hz), 5.74
(dqd, 1H, J 15.5, 6.4, 1.1 Hz), 6.90 (d, 1H, J 8.7 Hz); 13C NMR (126
MHz, CDCl3) δ 14.3 (CH3), 18.2 (CH3), 22.9 (CH2), 25.3 (CH3),
27.0 (CH3), 27.1 (CH2), 29.0 (CH2), 29.5 (CH2), 29.6 (CH2), 29.7
(CH2), 29.7 (CH2), 29.8 (CH2), 29.8 (2 × CH2), 29.9 (2 × CH2),
32.1 (CH2), 53.8 (CH), 77.6 (CH), 79.1 (CH), 92.9 (C), 108.5 (C),
126.7 (CH), 129.4 (CH), 161.0 (C); HRMS (ESI) calcd for
C25H44
35Cl3NNaO3 (MH
+), 534.2279; found, 534.2265.
(2S,3S,4R)-2-(2′,2′,2′-Trichloromethylcarbonylamino)-3,4-
(O-isopropylidene)octadecane-1,3,4-triol (32). (2E,4S,5S,6R)-4-
(2′,2′,2′-Trichloromethylcarbonylamino)-5,6-(O-isopropylidene)icos-
2-ene-5,6-diol (31) (0.057 g, 0.11 mmol) was dissolved in a mixture of
dichloromethane (10 mL) and methanol (10 mL), and the solution
was cooled to −78 °C. Ozone was bubbled through the reaction
mixture until the solution turned deep blue. After excess ozone was
purged with oxygen gas, a solution of sodium borohydride (0.013 g,
0.32 mmol) in ethanol (10 mL) was added dropwise with vigorous
stirring. The reaction mixture was allowed to slowly return to room
temperature over 5 h. The reaction mixture was quenched with a
saturated solution of ammonium chloride (10 mL), concentrated in
vacuo to an aqueous solution, and extracted with diethyl ether (3 × 15
mL). The combined organic layers were washed with water (20 mL)
and brine (20 mL), dried (MgSO4), and concentrated in vacuo to yield
the crude product. Puriﬁcation by column chromatography (diethyl
ether/petroleum ether 1:1) gave (2S,3S,4R)-2-(2′,2′,2′-trichlorome-
thylcarbonylamino)-3,4-(O-isopropylidene)octadecane-1,3,4-triol (32)
(0.041 g, 73%) as a colorless oil: IR (neat) 3307, 2918, 2849, 1687,
1533, 1221, 1047, 822 cm−1; [α]D
20 +4.8 (c 1.1, CHCl3);
1H NMR (500
MHz, CDCl3) δ 0.88 (t, 3H, J 7.0 Hz), 1.17−1.33 (m, 24H), 1.36 (s,
3H), 1.49 (s, 3H), 1.52−1.58 (m, 2H), 3.73 (dd, 1H, J 11.4, 3.2 Hz),
4.01 (dd, 1H, J 11.4, 3.2 Hz), 4.05 (ddt, 1H, J 8.4, 5.6, 3.2 Hz), 4.19−
4.26 (m, 2H), 7.18 (d, 1H, J 8.4 Hz); 13C NMR (126 MHz, CDCl3) δ
14.2 (CH3), 22.8 (CH2), 25.1 (CH3), 26.9 (CH2), 27.6 (CH3), 29.4
(CH2), 29.5 (CH2), 29.6 (CH2), 29.6 (CH2), 29.7 (CH2), 29.8 (CH2),
29.8 (CH2), 29.8 (CH2), 29.8 (2 × CH2), 32.1 (CH2), 52.1 (CH),
62.5 (CH2), 77.8 (CH), 77.8 (CH), 92.7 (C), 108.6 (C), 161.7 (C);
MS m/z 502 (MH+, 16), 444 (100), 410 (41), 329 (80), 313 (60), 271
(46), 257 (38), 219 (31), 172 (27), 148 (26), 73 (59); HRMS (CI)
calcd for C23H43
35Cl3NO4 (MH
+), 502.2258; found, 502.2264.
(2S,3S,4R)-2-Aminooctadecane-1,3,4-triol Hydrochloride
(3).10j (2S,3S,4R)-2-(2′,2′,2′-Trichloromethylcarbonylamino)-3,4-(O-
isopropylidene)octadecane-1,3,4-triol (32) (0.026 g, 0.05 mmol) was
dissolved in a mixture of dichloromethane (2 mL) and methanol (2
mL). Sodium hydroxide (4 M, 4 mL) was added, and the reaction
mixture was stirred for 60 h. The solution was extracted with
dichloromethane (3 × 20 mL), washed with water (3 × 20 mL), and
concentrated in vacuo. The crude oil was dissolved in a mixture of
dichloromethane (2 mL) and methanol (2 mL). To this solution was
added 6 M hydrochloric acid (2 mL), and the resulting solution was
stirred for 3 h at room temperature. The reaction was concentrated in
vacuo and washed with petroleum ether (3 × 10 mL) to yield
(2S,3S,4R)-2-aminooctadecane-1,3,4-triol hydrochloride (3) as a white
solid (0.015 g, 82%) (the spectroscopic data were as previously
reported10j): IR (neat) 3304 (OH), 2916 (CH), 2849 (CH), 1688,
1470, 1015 cm−1; [α]D
21 +4.8 (c 0.8, MeOH); 1H NMR (500 MHz,
CD3OD) δ 0.90 (t, 3H, J 7.0 Hz), 1.28−1.42 (m, 24H), 1.50−1.57 (m,
1H), 1.64−1.72 (m, 1H), 3.38−3.45 (m, 2H), 4.11 (ddd, 1H, J 8.8,
5.9, 3.2 Hz), 4.39 (t, 1H, J 8.8 Hz), 4.46 (dd, 1H, J 8.8, 5.9 Hz); 13C
NMR (126 MHz, CD3OD) δ 14.3 (CH3), 23.6 (CH2), 26.6 (CH2),
30.4 (CH2), 30.7 (2 × CH2), 30.7 (5 × CH2), 30.8 (CH2), 33.0
(CH2), 34.8 (CH2), 55.6 (CH), 67.4 (CH2), 74.0 (CH), 75.8 (CH);
HRMS (ESI) calcd for C18H40NO3 (MH
+), 318.3003; found,
318.2990.
(2E,4R,5S,6R)-4-(2′,2′,2′-Trichloromethylcarbonylamino)-
5,6-(O-isopropylidene)icos-2-ene-5,6-diol (33). The reactions
were carried out according to the procedure described for
(2E,4S,5S,6R)-4-(2′,2′,2′-trichloromethylcarbonylamino)-5,6-(O-
isopropylidene)icos-2-ene-5,6-diol (31) using (2R,3E,5S,6R)-5,6-(O-
isopropylidene)icos-3-ene-2,5,6-triol (30) (0.029 g, 0.08 mmol). This
yielded (2E,4R,5S,6R)-4-(2′,2′,2′-trichloromethylcarbonylamino)-5,6-
(O-isopropylidene)icos-2-ene-5,6-diol (33) (0.029 g, 71%) as a yellow
oil: IR (neat) 3426, 2922, 2853, 1719, 1495, 1213, 964, 820 cm−1;
[α]D
22 −12.6 (c 0.9, CHCl3); 1H NMR (500 MHz, CDCl3) δ 0.88 (t,
3H, J 7.0 Hz), 1.20−1.33 (m, 24H), 1.38 (s, 3H), 1.45−1.57 (m, 5H),
1.72 (ddd, 3H, J 6.5, 1.6, 0.9 Hz), 4.16−4.24 (m, 2H), 4.30−4.37 (m,
1H), 5.45 (ddq, 1H, J 15.3, 7.3, 1.6 Hz), 5.75 (dqd, 1H, J 15.3, 6.5, 0.9
Hz), 7.18 (d, 1H, J 7.0 Hz); 13C NMR (126 MHz, CDCl3) δ 14.3
(CH3), 18.0 (CH3), 22.9 (CH2), 24.4 (CH3), 27.2 (CH3), 27.3 (CH2),
29.3 (CH2), 29.5 (CH2), 29.6 (CH2), 29.6 (CH2), 29.7 (CH2), 29.8 (2
× CH2), 29.8 (CH2), 29.8 (CH2), 29.8 (CH2), 32.1 (CH2), 52.8
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(CH), 77.6 (CH), 78.9 (CH), 93.0 (C), 108.0 (C), 127.8 (CH), 129.0
(CH), 160.6 (C); MS m/z 512 (MH+, 32), 478 (84), 442 (100), 408
(55), 297 (20), 189 (34), 113 (14); HRMS (CI) calcd for
C25H45
35Cl3NO3 (MH
+), 512.2465; found, 512.2458.
(2R,3S,4R)-2-(2′,2′,2′-Trichloromethylcarbonylamino)-3,4-
(O-isopropylidene)octadecane-1,3,4-triol (34). The reactions
were carried out according to the procedure described for
(2S,3S,4R)-2-(2′ ,2′ ,2′-trichloromethylcarbonylamino)-3,4-(O-
isopropylidene)octadecane-1,3,4-triol (32) using (2E,4R,5S,6R)-4-
(2′,2′,2′-trichloromethylcarbonylamino)-5,6-(O-isopropylidene)icos-
2-ene-5,6-diol (33) (0.09 g, 0.18 mmol). This yielded (2R,3S,4R)-2-
(2′,2′,2′-trichloromethylcarbonylamino)-3,4-(O-isopropylidene)-
octadecane-1,3,4-triol (34) (0.058 g, 66%) as a colorless oil: IR (neat)
3419, 2922, 2853, 1717, 1502, 1211, 1050, 820 cm−1; [α]D
26 −20.5 (c
1.0, CHCl3);
1H NMR (500 MHz, CDCl3) δ 0.90 (t, 3H, J 6.9 Hz),
1.21−1.33 (m, 24H), 1.40 (s, 3H), 1.41−1.60 (m, 5H), 3.75 (dd, 1H, J
11.1, 6.4 Hz), 3.81 (dd, 1H, J 11.1, 5.1 Hz), 3.91−3.99 (m, 1H), 4.22−
4.30 (m, 1H), 4.42 (dd, 1H, J 7.1, 1.4 Hz), 7.27 (d, 1H, J 7.4 Hz); 13C
NMR (126 MHz, CDCl3) δ 14.2 (CH3), 22.8 (CH2), 24.5 (CH3),
27.2 (CH2), 27.2 (CH3), 29.4 (CH2), 29.5 (CH2), 29.5 (CH2), 29.6
(CH2), 29.6 (CH2), 29.7 (CH2), 29.7 (CH2), 29.8 (CH2), 29.8 (CH2),
29.8 (CH2), 32.1 (CH2), 52.7 (CH), 63.9 (CH2), 76.0 (CH), 77.7
(CH), 92.9 (C), 108.3 (C), 161.9 (C); MS m/z 502 (MH+, 18), 486
(14), 444 (100), 419 (34), 391 (42), 342 (37), 297 (68), 149 (11);
HRMS (CI) calcd for C23H43
35Cl3NO4 (MH
+), 502.2258; found,
502.2252.
(2R,3S,4R)-2-Aminooctadecane-1,3,4-triol Hydrochloride
(35).10j The reactions were carried out as described for D-ribo-
phytosphingosine hydrochloride (3) using (2R,3S,4R)-2-(2′,2′,2′-
trichloromethylcarbonylamino)-3,4-(O-isopropylidene)octadecane-
1,3,4-triol (34) (0.033 g, 0.07 mmol). This gave (2R,3S,4R)-2-
aminooctadecane-1,3,4-triol hydrochloride (35) as a white solid (0.020
g, 87%) (the spectroscopic data were as previously reported10j): IR
(neat) 3335 (NH/OH), 2916 (CH), 2849 (CH), 1472, 1418, 1034,
718 cm−1; [α]D
20 −12.2 (c 0.9, MeOH); 1H NMR (500 MHz, CD3OD)
δ 0.90 (t, 3H, J 7.0 Hz), 1.27−1.40 (m, 24H), 1.49−1.58 (m, 1H),
1.75 (td, 1H, J 9.4, 3.4 Hz), 3.19 (dd, 1H, J 8.1, 4.2 Hz), 3.42 (td, 1H, J
8.1, 3.4 Hz), 4.13 (ddd, 1H, J 8.9, 6.3, 4.2 Hz), 4.29 (dd, 1H, J 8.9, 6.3
Hz), 4.48 (t, 1H, J 8.9 Hz); 13C NMR (126 MHz, CD3OD) δ 14.3
(CH3), 23.6 (CH2), 26.5 (CH2), 30.4 (CH2), 30.7 (CH2), 30.7 (CH2),
30.7 (5 × CH2), 30.8 (CH2), 33.0 (CH2), 35.1 (CH2), 55.9 (CH),
69.2 (CH2), 73.9 (CH), 76.3 (CH); HRMS (ESI) calcd for
C18H40NO3 (MH
+), 318.3003; found, 318.2990.
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Wandosell, F.; Faircloth, G.; Fernańdez-Sousa, J. M.; Avila, J. Cancer
Lett. 2000, 152, 23.
(8) For reviews on the syntheses of sphingoid-type bases, see:
(a) Koskinen, P. M.; Koskinen, A. M. P. Synthesis 1998, 1075.
(b) Howell, A. R.; So, R. C.; Richardson, S. K. Tetrahedron 2004, 60,
11327. (c) Morales-Serna, J. A.; Llaveria, J.; Díaz, Y.; Matheu, M. I.;
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